Full Text View
Tabular View
No Study Results Posted
Related Studies
Enteroaggregative E.Coli (EAEC)
This study has been terminated.
Study NCT00362869   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on August 10, 2006.   Last Updated on March 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Escherichia Coli Infections
More general conditions related to this trial
Bacterial Infections
Enterobacteriaceae Infections
Gram-Negative Bacterial Infections
Interventions listed in this trial
Placebo
Enteroaggregative E. coli (EAEC)
Levofloxacin
Additional drug interventions recognized in this trial
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services